M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Sander

Germany
|
2022-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Merad

France
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Monkey vax

France
|
2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Non-hospital health centre
  • Vaccination centre
  • Monkeypox virus
  • Mpox
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Fontàn-Vela

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

COVA / RestPlus

The Netherlands
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Healthcare workers
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Agunbiade

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Mpox-Cohort

Italy
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN